Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Learn what's the best investment strategy to help you maximize your returns and achieve your financial goals.
22,631 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
President Donald Trump announces a sweeping 10% global tariff on imports, seeking to salvage a faltering trade agenda...
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
Jamie Dimon warns that AI could disrupt jobs sooner than expected and urges policymakers and businesses to start plan...
Four AI models project XRP’s 2026 end price in a wide band, signaling divergent bets on Ripple’s payment ambitions an...
The Pentagon has begun using low-cost drones modeled after Iran’s Shahed systems in recent strikes, raising questions...
As the energy transition gains pace, nuclear power moves back into the spotlight. This article breaks down two stock ...
As markets shift in 2026, retirees are seeking reliable income with inflation protection. This article breaks down fo...
A wave of retirees is piling into ultra-high-yield ETFs, chasing income. Yet by measuring total return after taxes an...
Citi's leadership under Jane Fraser is embracing Buffett-inspired rules to manage friction, keep decisions measured, ...
Intel faces a turning point as AI-driven demand and ramping foundry capacity shape intel corp (intc) stock. Analysts ...
Bitcoin surged past $74,000 as institutional buying returned to the market, sparking a wider crypto rally. Investors ...